76
Growth Score
pts
Heat Score
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
326269
Athebio is a biotechnology company that designs and develops binding proteins for drug developers.
- Joachim Schnabl: Co-founder | VP Digital Solutions
- Samuel Moser: Chief Operating Officer
About the Company
Athebio is a biotechnology company that designs and develops binding proteins for drug developers. Its modular platform enables partners to generate custom binders for diverse therapeutic areas, including oncology, gene therapy, and radioligand development. Athebio collaborates with global biopharma companies such as REGENXBIO, POINT Biopharma, and
3T Biosciences. The company’s mission is to expand the therapeutic potential of DARPins across multiple modalities. Through its platform-as-a-service approach, it accelerates the path from molecular design to clinical translation.
